Menu Close

Articles on Pfizer

Displaying 1 - 20 of 43 articles

For many, distinguishing between fact and fiction is difficult. Olemedia/E+ via Getty Images

6 important truths about COVID-19 vaccines

With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.
A health-care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a UHN COVID-19 vaccine clinic in Toronto on Thursday, January 7, 2021. THE CANADIAN PRESS/Nathan Denette

The roots of Canada’s COVID-19 vaccine shortage go back decades

Behind Canada’s current COVID-19 vaccine shortage is a decades-long tale of unheeded warnings, missed opportunities and dismantled resources that was never going to end well.
Patients with overweight or obesity issues make up more than 70% of the U.S. population. Peter Dazeley via Getty Images

Will the COVID-19 vaccine work as well in patients with obesity?

Americans with excess weight and obesity have been hit hard by COVID-19. Now there is reason to believe they may not get the same protection from the vaccines.
Getting vaccines to rural and hard-to-reach areas is critical for public health and ethical reasons. Hector Roqueta Rivero/Moment via Getty Images

The cold supply chain can’t reach everywhere – that’s a big problem for equitable COVID-19 vaccination

So far, the only COVID-19 vaccines authorized for use need to be kept frozen. But there are many places in the world that can't support a cold supply chain.
Efficient shipping and storage could prevent a lot of wasted vaccines. AP Photo/Morry Gash, Pool

What vaccine distribution planners can learn from Amazon and Walmart

COVID-19 vaccines have very specific storage requirements that make shipping a difficult task. Two ideas – fulfillment centers and cross-docking – could help overcome some distribution challenges.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool. (Shutterstock)

Can a pharma company change? Profit, not altruism, motivates COVID-19 vaccine development

We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Tony Potts, a 69-year-old retiree, removes his face mask for a temperature check just before receiving his first injection in a phase 3 COVID-19 vaccine clinical trial sponsored by Moderna. Potts is one of 30,000 participants in the Moderna trial. Paul Hennessy/NurPhoto via Getty ImageS

What are emergency use authorizations, and do they guarantee that a vaccine or drug is safe?

The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?

Top contributors

More